Speakers

Bryan Newman, PhD, is a Lead Pharmacologist and team lead for nasal and inhalation drug products in the Division of Therapeutic Performance 1 (DTP-1), Office of Research and Standards (ORS) in the Office of Generic Drugs (OGD). Dr. Newman’s work focuses on developing product-specific guidances, along with addressing controlled correspondences, citizen petitions, consults, and pre-ANDA meeting requests. He also serves as a project officer and contracting officer’s representative for regulatory science research initiatives related to nasal and inhalation drug products. Dr. Newman received his B.S. degree from Louisiana State University in Biochemistry and his M.S. and Ph.D. degrees in Pharmaceutical Science from the University of Michigan.